Discover MabDesign
MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.

Access our network
Join the MabDesign network to take advantage of all the advantages and opportunities offered.

Develop your skills
Consult and register for our next training courses in order to acquire new expertise.

Explore our business services
The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.

Upcoming events
Add your title here
31
Mar.
31 March 2025
Call for Projects
15
Apr.
April 15-17, 2025
Partner Event
28
Apr.
April 28-30, 2025
Partner Event
05
May.
May, 5-6 2025
Partner Event
22
May.
May 22-23, 2025
Mabdesign Event
02
Jun.
June 2nd, 2025
Mabdesign Event
Our News

ZOOM ON - Ypso-Facto
Ypso-Facto helps pharmaceutical companies develop, optimize, and secure bioprocesses.
By combining scientific expertise with industrial experience, we offer consulting services and innovative software solutions to enhance efficiency, sustainability, and performance in API process development and manufacturing.

EPIGENE LABS ANNOUNCES MULTI-YEAR EXPANSION OF COLLABORATIONWITH SERVIER TO ADVANCE AI-DRIVEN PRECISION ONCOLOGY R&D
Epigene Labs, a techbio company focused on creating intelligence-augmenting solutions for precision oncology, today announced an expanded multi-year collaboration with Servier, an independent international pharmaceutical group.

Les Laboratoires Pierre Fabre et RedRidge Bio annoncent un partenariat concernant la découverte et le co-développement de candidats médicament
Les Laboratoires Pierre Fabre et RedRidge Bio (« RedRidge ») annoncent aujourd’hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de développer des candidats-médicaments à base d'anticorps biparatopiques (ABP) contre plusieurs cibles.
OUR BOARD OF DIRECTORS








